| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
44,930,000 |
| Market
Cap: |
64.25(M) |
| Last
Volume: |
12,450 |
Avg
Vol: |
313,362 |
| 52
Week Range: |
$1.28 - $2.6 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile MediciNova is a biopharmaceutical company. Co. is focusing its development activities on MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, substance dependence and addiction and prevention of acute respiratory distress syndrome, and MN-001 (tipelukast) for fibrotic diseases such as nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis. Co.'s pipeline also includes MN-221 (bedoradrine) for the treatment of acute exacerbation of asthma and MN-029 (denibulin) for solid tumor cancers.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
12,646 |
| Total Sell Value |
$0 |
$0 |
$0 |
$28,031 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
4 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Iwaki Yuichi |
President and CEO |
• • – |
2018-01-03 |
4 |
OE |
$4.42 |
$235,864 |
D/D |
53,363 |
690,591 |
|
- |
|
| Okajima Masatsune |
VP and Head of Japanese Office |
• – – |
2017-12-12 |
4 |
OE |
$4.42 |
$212,160 |
D/D |
48,000 |
108,941 |
|
- |
|
| Iwaki Yuichi |
President and CEO |
• • – |
2017-11-02 |
4 |
OE |
$4.42 |
$93,116 |
D/D |
21,067 |
637,228 |
|
- |
|
| Ishizaka Yoshio |
Director |
– • – |
2017-08-21 |
4 |
B |
$5.17 |
$25,850 |
I/I |
5,000 |
10,000 |
2.1 |
- |
|
| Kobayashi Yutaka |
Director |
– • – |
2017-05-15 |
4 |
B |
$5.60 |
$5,600 |
I/I |
1,000 |
25,000 |
2.1 |
- |
|
| Kobayashi Yutaka |
Director |
– • – |
2017-05-12 |
4 |
B |
$5.62 |
$134,880 |
I/I |
24,000 |
24,000 |
2.1 |
- |
|
| Kobayashi Yutaka |
Director |
– • – |
2016-09-15 |
4 |
B |
$6.44 |
$75,992 |
D/D |
11,800 |
81,800 |
2.39 |
- |
|
| Kobayashi Yutaka |
Director |
– • – |
2016-09-09 |
4 |
B |
$6.67 |
$66,700 |
D/D |
10,000 |
70,000 |
2.39 |
- |
|
| Obrien Geoffrey |
Vice President |
• – – |
2016-07-05 |
4 |
AS |
$8.00 |
$26,400 |
D/D |
(3,300) |
5,000 |
|
- |
|
| Obrien Geoffrey |
Vice President |
• – – |
2016-07-05 |
4 |
OE |
$4.80 |
$15,840 |
D/D |
3,300 |
8,300 |
|
- |
|
| Matsuda Kazuko |
Chief Medical Officer |
• – – |
2016-03-14 |
4 |
OE |
$3.56 |
$2,848 |
D/D |
800 |
62,003 |
|
- |
|
| Okajima Masatsune |
VP and Head of Japanese Office |
• – – |
2016-03-14 |
4 |
OE |
$3.56 |
$29,904 |
D/D |
8,400 |
51,138 |
|
- |
|
| Kobayashi Yutaka |
Director |
– • – |
2014-12-10 |
4 |
B |
$3.54 |
$42,480 |
D/D |
12,000 |
60,000 |
2.39 |
- |
|
| Kobayashi Yutaka |
Director |
– • – |
2014-11-26 |
4 |
B |
$3.07 |
$30,700 |
D/D |
10,000 |
48,000 |
2.39 |
- |
|
| Kobayashi Yutaka |
Director |
– • – |
2014-11-20 |
4 |
B |
$3.19 |
$41,470 |
D/D |
13,000 |
38,000 |
2.39 |
- |
|
| Ishizaka Yoshio |
Director |
– • – |
2014-11-19 |
4 |
B |
$2.86 |
$14,300 |
I/I |
5,000 |
5,000 |
2.1 |
- |
|
| Kobayashi Yutaka |
Director |
– • – |
2014-09-11 |
4 |
B |
$2.95 |
$29,500 |
D/D |
10,000 |
25,000 |
2.39 |
- |
|
| Kobayashi Yutaka |
Director |
– • – |
2014-09-03 |
4 |
B |
$2.63 |
$39,849 |
D/D |
15,000 |
15,000 |
2.39 |
- |
|
43 Records found
|
|
Page 2 of 2 |
|
|
0.06 (4.03%) 
